Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-28 @ 9:38 AM
Study NCT ID:
NCT05255861
Status:
UNKNOWN
Last Update Posted:
2022-02-25
First Post:
2022-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Exploratory Study of HRD Score in Chinese Ovarian Cancer Patients Benefiting From PARP Inhibitor Targeted Therapy
Sponsor:
Xin Wu
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-15
First Submit QC Date:
None
Study First Post Date:
2022-02-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-24
Last Update Post Date:
2022-02-25
Last Update Post Date Type:
ACTUAL